TY - JOUR
T1 - The FBXW7-NOTCH interactome
T2 - A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues
AU - Kar, Rohan
AU - Jha, Saurabh Kumar
AU - Ojha, Shreesh
AU - Sharma, Ankur
AU - Dholpuria, Sunny
AU - Raju, Venkata Sita Rama
AU - Prasher, Parteek
AU - Chellappan, Dinesh Kumar
AU - Gupta, Gaurav
AU - Kumar Singh, Sachin
AU - Paudel, Keshav Raj
AU - Hansbro, Philip M.
AU - Kumar Singh, Sandeep
AU - Ruokolainen, Janne
AU - Kesari, Kavindra Kumar
AU - Dua, Kamal
AU - Jha, Niraj Kumar
N1 - Funding Information:
The authors would like to express their gratitude to the unknown referees for carefully reading the paper and giving valuable suggestions.
Publisher Copyright:
© 2021 The Authors. Cancer Reports published by Wiley Periodicals LLC.
PY - 2021/8
Y1 - 2021/8
N2 - Background: Ubiquitin ligases or E3 ligases are well programmed to regulate molecular interactions that operate at a post-translational level. Skp, Cullin, F-box containing complex (or SCF complex) is a multidomain E3 ligase known to mediate the degradation of a wide range of proteins through the proteasomal pathway. The three-dimensional domain architecture of SCF family proteins suggests that it operates through a novel and adaptable “super-enzymatic” process that might respond to targeted therapeutic modalities in cancer. Recent findings: Several F-box containing proteins have been characterized either as tumor suppressors (FBXW8, FBXL3, FBXW8, FBXL3, FBXO1, FBXO4, and FBXO18) or as oncogenes (FBXO5, FBXO9, and SKP2). Besides, F-box members like βTrcP1 and βTrcP2, the ones with context-dependent functionality, have also been studied and reported. FBXW7 is a well-studied F-box protein and is a tumor suppressor. FBXW7 regulates the activity of a range of substrates, such as c-Myc, cyclin E, mTOR, c-Jun, NOTCH, myeloid cell leukemia sequence-1 (MCL1), AURKA, NOTCH through the well-known ubiquitin-proteasome system (UPS)-mediated degradation pathway. NOTCH signaling is a primitive pathway that plays a crucial role in maintaining normal tissue homeostasis. FBXW7 regulates NOTCH protein activity by controlling its half-life, thereby maintaining optimum protein levels in tissue. However, aberrations in the FBXW7 or NOTCH expression levels can lead to poor prognosis and detrimental outcomes in patients. Therefore, the FBXW7-NOTCH axis has been a subject of intense study and research over the years, especially around the interactome's role in driving cancer development and progression. Several studies have reported the effect of FBXW7 and NOTCH mutations on normal tissue behavior. The current review attempts to critically analyze these mutations prognostic value in a wide range of tumors. Furthermore, the review summarizes the recent findings pertaining to the FBXW7 and NOTCH interactome and its involvement in phosphorylation-related events, cell cycle, proliferation, apoptosis, and metastasis. Conclusion: The review concludes by positioning FBXW7 as an effective diagnostic marker in tumors and by listing out recent advancements made in cancer therapeutics in identifying protocols targeting the FBXW7-NOTCH aberrations in tumors.
AB - Background: Ubiquitin ligases or E3 ligases are well programmed to regulate molecular interactions that operate at a post-translational level. Skp, Cullin, F-box containing complex (or SCF complex) is a multidomain E3 ligase known to mediate the degradation of a wide range of proteins through the proteasomal pathway. The three-dimensional domain architecture of SCF family proteins suggests that it operates through a novel and adaptable “super-enzymatic” process that might respond to targeted therapeutic modalities in cancer. Recent findings: Several F-box containing proteins have been characterized either as tumor suppressors (FBXW8, FBXL3, FBXW8, FBXL3, FBXO1, FBXO4, and FBXO18) or as oncogenes (FBXO5, FBXO9, and SKP2). Besides, F-box members like βTrcP1 and βTrcP2, the ones with context-dependent functionality, have also been studied and reported. FBXW7 is a well-studied F-box protein and is a tumor suppressor. FBXW7 regulates the activity of a range of substrates, such as c-Myc, cyclin E, mTOR, c-Jun, NOTCH, myeloid cell leukemia sequence-1 (MCL1), AURKA, NOTCH through the well-known ubiquitin-proteasome system (UPS)-mediated degradation pathway. NOTCH signaling is a primitive pathway that plays a crucial role in maintaining normal tissue homeostasis. FBXW7 regulates NOTCH protein activity by controlling its half-life, thereby maintaining optimum protein levels in tissue. However, aberrations in the FBXW7 or NOTCH expression levels can lead to poor prognosis and detrimental outcomes in patients. Therefore, the FBXW7-NOTCH axis has been a subject of intense study and research over the years, especially around the interactome's role in driving cancer development and progression. Several studies have reported the effect of FBXW7 and NOTCH mutations on normal tissue behavior. The current review attempts to critically analyze these mutations prognostic value in a wide range of tumors. Furthermore, the review summarizes the recent findings pertaining to the FBXW7 and NOTCH interactome and its involvement in phosphorylation-related events, cell cycle, proliferation, apoptosis, and metastasis. Conclusion: The review concludes by positioning FBXW7 as an effective diagnostic marker in tumors and by listing out recent advancements made in cancer therapeutics in identifying protocols targeting the FBXW7-NOTCH aberrations in tumors.
KW - E3 ligase
KW - FBXW7
KW - NOTCH
KW - SCF
KW - cancer
KW - diagnostic markers
KW - mutation
KW - therapeutics
UR - http://www.scopus.com/inward/record.url?scp=85103557988&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103557988&partnerID=8YFLogxK
U2 - 10.1002/cnr2.1369
DO - 10.1002/cnr2.1369
M3 - Review article
C2 - 33822486
AN - SCOPUS:85103557988
SN - 2573-8348
VL - 4
JO - Cancer Reports
JF - Cancer Reports
IS - 4
M1 - e1369
ER -